Literature DB >> 25013663

Survival rate in lung, liver, heart and pancreas transplant recipients in iran: a registry-based study.

Fatemeh Ghaemi1, Farahnaz Ghaemi2, M Zamyad1.   

Abstract

BACKGROUND: The main purpose of organ transplantation is to prolong and maintain a quality life for patients with organ dysfunction.
OBJECTIVE: We tried to evaluate short-term survival rates in lung, liver, heart and pancreas recipients.
METHODS: This longitudinal study was based on the data of national registry of recipients in Ministry of Health and Medical Education (MOHME), Iran. Survival rate after 1 year of transplantation, recipients' age, gender, ischemic time as well as the number of transplantation units, OP units and identification units were collected from the database for all transplantation done between 2010 and 2011.
RESULTS: 407 (223 female, and 184 male) patients were enrolled in the study. 13 (3.2%) patients received lung, 299 (73.5%) liver, 85 (20.9%) heart and 10 (2.5%) received pancreas. Within 1 year of transplantation, 61.5% of lung recipients, 88.3% of liver recipients, 72.9% of heart recipients and 80% of pancreas recipients (overall 85.3%) were functioning.
CONCLUSION: Given the short history of transplantation in Iran, we have achieved great success.

Entities:  

Keywords:  Lung transplantation; heart transplantation; ischemic time; liver transplantation; pancreas transplantation; recipient survival rate

Year:  2013        PMID: 25013663      PMCID: PMC4089316     

Source DB:  PubMed          Journal:  Int J Organ Transplant Med        ISSN: 2008-6482


INTRODUCTION

Nowadays, patients with untreatable end-stage organ disease are considered for organ transplantation [1-3]. The major constraint on meeting the demand for transplantation is the availability of donated (cadaver) organs [4, 5]. Introduction of new immunosuppressants over the past 20 years along with improvements achieved in infection prophylaxis strategies, have resulted in a remarkable improvement in both patients and grafts survival rates. These factors have changed organ transplantation into the treatment of choice for patients with end-stage organ disease [6, 7]. However, other factors such as age and gender of recipients and donors, background diseases and cold ischemic time can change survival rate [8-10]. Therefore, we conducted this study to assess the short-term survival rate in lung, liver, heart and pancreas transplant recipients based on data of the Ministry of Health and Medical Education (MOHME) registry, Iran.

PATIENTS AND METHODS

This longitudinal study was based on the data retrieved from Iranian MOHME registry. All requests for lung, liver, heart and pancreas are registered in MOHME transplantation database by the staff in the transplantation wards of hospitals in Iran. The recipients are followed after transplantation in two ways: first, the patients are followed in the same hospital where transplantation took place; second, the staff members of the transplantation department in the Ministry of Health follow them up by phone. The staff members of the transplantation wards in all hospitals are required to enter the results of follow-ups into the said database. However, owing to some limitations, not all the required data are entered into the database. The only piece of information that is received for all cases is their death/survival. The total number of people having organ transplantation in Iran in 2010 was 2454; of these, 407 were studied in the present research (transplantations in 2010 and 2011); the rest of patients have had kidney transplantation which is not the focus of this study. Of 407 recipients, 223 (54.8%) were female and 184 (45.2%) were male. All recipients receiving lung, liver, heart and pancreas were followed for one year. In all cases of transplantation, donors and recipients did not know each other; the only exception was in case of living donors of liver where both the recipient and donor were related. Then relevant data on recipients including their number, age, gender, and cold ischemic time, survival and death within one year after transplantation, donors’ characteristics (i.e., deceased or live) as well as the organ transplantation center were collected and tabulated.

RESULTS

Most of the liver transplant donors were deceased. Table 1 shows data on active centers in Iran where lung, liver, heart and pancreas are transplanted. Table 2 demonstrates the total number of recipients as well as their gender, age and cold ischemic time. Table 3 depicts the distribution of transplants stratified by type of donor. Table 4 reveals recipients’ survival within one year of transplantation stratified by type of donor.
Table 1

Active organ transplantation centers in Iran

OrganNo. of transplantation unitsNo. of organ procurement unitsNo. of identification units
Lung21430
Liver5
Heart4
Pancreas1
Total121430
Table 2

Recipients’ data

OrganTotal No. of recipientsNo. of female recipientsMean age (yrs)Cold ischemic time (h)
Lung13 (3.2%)4 (31%)34.32–4
Liver299 (73.5%)191 (63.9%)33.23–8
Heart85 (20.9%)23 (27%)33.42–4
Pancreas10 (2.5%)5 (50%)29.83–8
Total407223 (54.8%)
Table 3

Distribution of transplants stratified by type of donor

No.OrganTotal No. of RecipientsNo. of Recipients from Deceased DonorsNo. of Recipients from Live Donors
1Lung13 (3.20%)13 (3.20%)0
2Liver299 (73.46%)252 (84.28%)47 (15.72%)
3Heart85 (20.88%)85 (20.88%)0
4Pancreas10 (2.46%)10 (2.46%)0
Total40737136
Table 4

Recipients’ survival within one year of transplantation

OrganTotal No. of recipientsNo. of active recipients from deceased donorsNo. of inactive recipients from deceased donorsNo. of active recipients from live donorsNo. of inactive recipients from live donors
Lung138 (62%)5 (38%)0 (0%)0 (0%)
Liver299222 (74.3%)30 (10.0%)42 (14.1%)5 (1.7%)
Heart8562 (73%)23 (27%)0 (0%)0 (0%)
Pancreas108 (80%)2 (20%)0 (0%)0 (0%)
Total40730060425
Active organ transplantation centers in Iran Recipients’ data Distribution of transplants stratified by type of donor Recipients’ survival within one year of transplantation

DISCUSSION

Over the past decade, with improvements in organ transplantation, the number of indications for organ transplantation has continuously grown and the need for organ donation has steadily increased. Our results showed that transplanted organs were functioning in majority of recipients (85.3%) within one year of transplantation. Because there has been only a short period (10 years) since the establishment of transplantation law from deceased donors in Iran, this survival rate can be considered a success. This significant success could not have been achieved without the painstaking efforts of our dedicated physicians and staff members as well as the recipient, donor and allocation coordinators. We owe a lot to the hardworking staff members in transplantation units, identification units and OPUs. The support and cooperation we have received from the authorities of hospitals, universities and the Ministry of Health need appreciation too. The small number of failures in our series may be attributed to lack of facilities and trained personnel in other universities. We hope to achieve better results in near future by increasing the number of transplantation wards, OPUs, and identification units in hospitals all over the country. An increase in the number of well-equipped centers will hopefully reduce ischemic time. Training people on how to prevent organ failure can also diminish the demand for organ transplantation. Besides, good patient follow-up after transplantation may decrease the complications and increase the survival rate [11, 12].
  10 in total

1.  Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial.

Authors:  Daniel Shoskes; Chantale Lapierre; Marcia Cruz-Correa; Marcia Cruz-Corerra; Nicolas Muruve; Reinaldo Rosario; Beth Fromkin; Mauro Braun; John Copley
Journal:  Transplantation       Date:  2005-12-15       Impact factor: 4.939

2.  Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation.

Authors:  D L Gillen; C O Stehman-Breen; J M Smith; R A McDonald; B A Warady; J R Brandt; C S Wong
Journal:  Am J Transplant       Date:  2008-09-18       Impact factor: 8.086

3.  Results of kidney transplantation from 1979 to 1997 at Yonsei University.

Authors:  K Park; S I Kim; Y S Kim; J I Moon; K H Choi; H Y Lee; D S Han; P K Kim
Journal:  Clin Transpl       Date:  1997

Review 4.  Liver transplantation. Selection, listing criteria, and preoperative management.

Authors:  S Saab; S H Han; P Martin
Journal:  Clin Liver Dis       Date:  2000-08       Impact factor: 6.126

5.  Effect of first-day graft nonfunction on the short- and long-term graft survival rates in living related and living unrelated donor renal transplants.

Authors:  A J Ghods; P Khosravani
Journal:  Transplant Proc       Date:  1997-11       Impact factor: 1.066

6.  Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients.

Authors:  Herwig-Ulf Meier-Kriesche; Akinlolu O Ojo; Friedrich K Port; Julie A Arndorfer; Diane M Cibrik; Bruce Kaplan
Journal:  J Am Soc Nephrol       Date:  2001-06       Impact factor: 10.121

7.  A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.

Authors:  F Kanwal; G S Dulai; B M R Spiegel; H F Yee; I M Gralnek
Journal:  Aliment Pharmacol Ther       Date:  2005-01-15       Impact factor: 8.171

8.  Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.

Authors:  Amr A El-Husseini; Mohamed A Foda; Ahmed A Shokeir; Ahmed B Shehab El-Din; Mohamed A Sobh; Mohamed A Ghoneim
Journal:  Pediatr Transplant       Date:  2005-12

9.  End-stage renal disease and its treatment in Latin America in the twenty-first century.

Authors:  Ana Cusumano; Guillermo Garcia-Garcia; Cristina Di Gioia; Osvaldo Hermida; Carlos Lavorato; Cesar Agost Carreño; Maria Placida Garron Torrico; Paulo Benigno Pena Batista; João Egídio Romão; Hugo Poblete Badal; Susana Elgueta Miranda; Rafael Gomez; Manuel Cerdas Calderon; Sergio Herra Sanchez; Miguel Almaguer Lopez; Julio Moscoso; Ricardo Leiva Merino; Jose Vicente Sánchez Polo; Alirio Lopez; Norman Jiron Romero; Ramiro Garcia; Blanca V Franco Acosta; Augusto Saavedra Lopez; Eduardo Santiago Delpin; Emilio Mena; Carlota González; Carmen Luisa Milanés; Sergio Acchiardo
Journal:  Ren Fail       Date:  2006       Impact factor: 2.606

10.  Factors affecting survival in kidney recipients at kermanshah.

Authors:  Mohammad Rezaei; A Kazemnejad; Ar Bardideh; M Mahmoudi
Journal:  Urol J       Date:  2004       Impact factor: 1.510

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.